Literature DB >> 7197593

Treatment of diffuse pleural malignant mesothelioma by cis dichloro diammine platinum (C.D.D.P.) in nine patients.

G Dabouis, B Le Mevel, J Corroller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7197593     DOI： 10.1007/bf00258484

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  8 in total

1.  Mesothelioma on the coast of Brittany, France.

Authors:  M de Lajartre; A Y de Lajartre
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

Review 2.  Malignant mesothelioma. Current status and future prospects.

Authors:  J Aisner; P H Wiernik
Journal:  Chest       Date:  1978-10       Impact factor: 9.410

3.  Mesothelioma and local immunotherapy.

Authors:  S Sone; E Tsubura
Journal:  Ann Intern Med       Date:  1978-04       Impact factor: 25.391

4.  Diffuse pleural mesothelioma. A clinical and pathological study.

Authors:  G H Roberts
Journal:  Br J Dis Chest       Date:  1970-10

5.  Epidemiology of primary malignant mesothelial tumors in Canada.

Authors:  A D McDonald; A Harper; J C McDonald; O A el-Attar
Journal:  Cancer       Date:  1970-10       Impact factor: 6.860

Review 6.  Therapeutic approaches in malignant mesothelioma.

Authors:  S S Legha; F M Muggia
Journal:  Cancer Treat Rev       Date:  1977-03       Impact factor: 12.111

Review 7.  Treatment of diffuse malignant mesothelioma: a review.

Authors:  A P Chahinian; J F Holland
Journal:  Mt Sinai J Med       Date:  1978 Jan-Feb

8.  The value of adriamycin in the treatment of diffuse malignant pleural mesothelioma.

Authors:  B S Yap; R S Benjamin; M A Burgess; G P Bodey
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860
  8 in total
  3 in total

Review 1.  Chemotherapy in malignant mesothelioma: a review.

Authors:  A Krarup-Hansen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  A phase II study of VP-16 and cisplatin in patients with unresectable malignant mesothelioma. An NCI Canada Clinical Trials Group Study.

Authors:  E A Eisenhauer; W K Evans; N Murray; W Kocha; R Wierzbicki; K Wilson
Journal:  Invest New Drugs       Date:  1988-12       Impact factor: 3.850

3.  Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients.

Authors:  D J Sugarbaker; J P Garcia; W G Richards; D H Harpole; E Healy-Baldini; M M DeCamp; S J Mentzer; M J Liptay; G M Strauss; S J Swanson
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.